Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Use this AVDL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AVDL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AVDL SEC filings page. Lician reads the product cache first so this HTML stays unique to Avadel Pharmaceuticals PLC even when a live quote feed is slow.
Latest cached year on this hub. Full AVDL income, balance, and cash tables.